Histamine and histamine receptor antagonists in cancer biology

Inflammation and Allergy - Drug Targets

Volumn 9, Issue 3, 2010, Pages 146-157

  Blaya, Bruno ^a   Nicolau Galmés, Francesca ^a   Jangi, Shawkat M ^b   Ortega Martínez, Idoia ^a   Alonso Tejerina, Erika ^a   Burgos Bretones, Juan ^c   Pérez Yarza, Gorka ^a   Asumendi, Aintzane ^a   Boyano, María D ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HAWLER MEDICAL UNIVERSITY   (Iraq)

^c HOSPITAL DE CRUCES   (Spain)

Author keywords

Antihistamines; Cancer; Histamine; Histamine receptors; Melanoma

Indexed keywords

ACRIVASTINE; ANTIHISTAMINIC AGENT; ASTEMIZOLE; AZELASTINE; CAREBASTINE; CETIRIZINE; CIMETIDINE; DEXCHLORPHENIRAMINE; EBASTINE; EMEDASTINE; EPINASTINE; ERYTHROMYCIN; FAMOTIDINE; FEXOFENADINE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTAMINE H4 RECEPTOR; HISTAMINE H4 RECEPTOR ANTAGONIST; HYDROXYZINE; KETOCONAZOLE; LORATADINE; MIZOLASTINE; RANITIDINE; TERFENADINE; UNINDEXED DRUG;

ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTICHOLINERGIC EFFECT; ANTINEOPLASTIC ACTIVITY; ANXIETY; APOPTOSIS; ARTICLE; ATOPIC DERMATITIS; AUTOCRINE EFFECT; BLURRED VISION; CANCER GROWTH; CARDIOTOXICITY; CELL DIFFERENTIATION; CELL MIGRATION; CELL VIABILITY; CLONOGENESIS; COMMON COLD; CONCENTRATION RESPONSE; CONFUSION; CONSTIPATION; CONTACT DERMATITIS; COORDINATION DISORDER; COUGHING; CROHN DISEASE; CYTOTOXICITY; DIARRHEA; DIZZINESS; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG METABOLISM; DRY COUGH; EUPHORIA; FATIGUE; GYNECOMASTIA; HALLUCINATION; HEADACHE; HEART PALPITATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HISTAMINE RELEASE; HUMAN; HYPOTENSION; INSECT BITE; INSOMNIA; MELANOMA; MELANOMA CELL; MOTION SICKNESS; MULTIPLE SCLEROSIS; NAUSEA; NONHUMAN; PSYCHOSIS; QT PROLONGATION; SEDATION; SIDE EFFECT; STOMACH FUNCTION DISORDER; TINNITUS; TREMOR; URINE RETENTION; URTICARIA; VOMITING; XEROSTOMIA;

EID: 77958495125     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152810792231869     Document Type: Article

References (101)

1. Dale, H.H.; Laidlaw, P.P. The physiological action of Bimadozolylethylamine. J. Physiol., 1910, 41, 318.
2. Dale, H.H.; Laidlaw, P.P. Histamine shock. J. Physiol., 1919, 52, 355.
3. Willian, P. Fundamental immunology. New York, NH: Raven Press, 1984, p. 716.
4. Falcone, F.H.; Zillikens, D.; Gibbs, B.F. The 21st centuty renaissance of the basophils? Current insights into its role in allergic reponses and innate immunity. Exp. Dermatol., 2006, 15, 855.
5. Rang, H.P.; Urban, L. New molecules in analgesia. Br. J. Anaesth., 1995, 75, 145.
6. Masini, E.; Di Bello, M.G.; Raspanti, S.; Fomusi, N.; Disang, J.; Baronti, R.; Cappugi, P.; Mannaioni, P.F. The role of histamine in platelet aggregation by physiological and immunological stimuli. Inflammat. Res., 1998, 47, 211.
7. Zwadlo-Klarwasser, G.; Braan, U.; Muhl-Zurbes, P.; Schumutzler, W. Macrophages and lymphocytes: alternative sources of histamine. Agents Actions, 1994, 41 /SPEC.ISS), C99-C100.
8. Maslinska, D.; Gujski, M.; Laure-Kamionowska, M.; Szukiewicz, D.; Wojtecka-Lukasik, E. Subcellular localization of histamine in articular cartilage chondrocytes of rheumatoid arthritis patients. Imflamm. Res., 2004, 53, S35.
9. Arrang, J.M.; Garbarg, M.; Schuwartz, J.C. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature, 1983, 302, 832.
10. Prinz, C., Zanner, R., Gratzl, M. Physiological of Gastric Enterochromaffin-Like Cells. 65. Book Monograph, 2003, pp. 371.
11. Falus, A.; Hegyesi, H.; Lázár-Molnár, E.; Pós, Z.; László, Z. Paracrine and autocrine interactions inmelanoma: histamine is a relevant player in local regulations. Trend Immunol., 2001, 22, 648.
12. Radvány, Z.; Darvas, Z.; Kerekes, K.; Prech, J.; Szalai, C.; Pállinger, E.; Valéria, L.; Varga, V.L.; Sandor, M.; Erdei, A.; Falus, A. H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells. Semin Cancer Biol., 2000, 10, 41.
13. Granerus, G.; Olafsson, J.H.; Roupe, G. Studies on histamine metabolism in masticytosis. J. Invest. Dermatol., 1983, 80, 410.
14. Keyzer, M.; De Monchy, J.D.; van Doormaal, J.J.; Van-Voorst Vader, P.C. Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites. N. Engl. J. Med., 1983, 309, 1603.
15. Hofstra, C.L., Desai, P.J., Thurmond, R.L., Fung-Leung, W.P. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther., 2003, 305, 1212.
16. Nguyen, T.; Shapiro, D.A.; George, S.R.; Setola, V.; Lee, D.K.; Cheng, R.; Rauser, L.; Lee, S.P.; Lynch, K.R.; Roth, B.L.; O'Dowd, B.F. Discovery of a novel member of the histamine receptor family. Mol. Pharmacol,. 2001, 59, 427.
17. Brandes, L.J.; Davie, J.R.; Paraskevas, F.; Sukhu, B.; Bogdanovic, R.P.; La Bella, F.S. The antiproliferative potency of histamine antagonists correlates with inhibition of binding of [3H]-histamine to novel intracellular receptors (HIC) in microsomal and nuclear fractions of rat liver. Agents Actions Suppl., 1991, 33, 325.
18. Hill, S.J. Distribution, properties and functional characteristics of three classes of histamine receptor. Pharmacol. Rev., 1990, 42, 45.
19. Yamashita, M.; Fukui, H.; Sugama, K.; Horio, Y.; Ito, S.; Mizuguchi, H.; Wada, H. Expression cloning of a cDNA encoding the bovine histamine H1 receptor. Proc. Natl. Acad. Sci. U S A., 1991, 88, 11515.
20. Hill, S.J.; Ganellin, C.R.; Timmerman, H.; Schwartz, J.C.; Shankley, N.P.; Young, J.M.; Schunack, W.; Levi, R.; Haas, H.L. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol. Rev., 1997, 49, 253.
21. Le Coniat, M.; Traiffort, E.; Ruat, M.; Arrang, J.M.; Berger, R. Chromosomal localization of the human histamine H1-receptor gene. Hum. Genet., 1994, 94, 186.
22. Leurs, R.; Smit, M.J.; Timmerman, H. Molecular pharmacological aspects of histamine receptors. Pharmacol. Ther., 1995, 66, 413.
23. Megson, A.C.; Walker, E.M.; Hill, S.J. Role of protein kinase Ca in signalling from the histamine H1 receptor to the nucleus. Mol. Pharmacol., 2001, 59, 1012.
24. Schmidt, G., Kannisto, P., Owman, C. Histaminergic effects on the isolated rat ovarian artery during the estrous cycle. Biol. Reprod., 1990, 42, 762.
25. Yuan, Y.; Granger, H.J.; Zawieja, D.C.; DeFily, D.V.; Chilian, W.M. Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. Am. J. Physiol., 1993, 264, H1734.
26. Jutel, M.; Akdis, M.; Akdis, C.M. Histamine, histamine receptors and their role in immune paphology. Clin. Exp. Allergy., 2009, 39, 1786.
27. Gantz, I.; Munzert, G.; Tashiro, T.; Schäffer, M.; Wang, L.; DelValle, J.; Yamada, T. Molecular cloning of the human histamine H2 receptor. Biochem. Biophys. Res. Commun., 1991, 178, 1386.
28. Gantz, I.; Schäffer, M.; DelValle, J.; Logsdon, C.; Campbell, V.; Uhler, M.; Yamada, T. Molecular cloning of a gene encoding the histamine H2 receptor. Proc. Natl. Acad. Sci. U S A., 1991, 88, 5937
29. Ruat, M.; Traiffort, E.; Arrang, J.M.; Leurs, R.; Schwartz, J.C. Cloning and tissue expression of a rat histamine H2-receptor gene. Biochem. Biophys. Res. Commun., 1991, 179, 1470.
30. Kobayashi, T.; Inoue, I.; Jenkins, N.A.; Gilbert, D.J.; Copeland, N.G.; Watanabe, T. Cloning, RNA expression, and chromosomal location of a mouse histamine H2 receptor gene. Genomic., 1996, 37, 390.
31. Traiffort, E.; Vizuete, M.L.; Tardivel-Lacombe, J.; Souil, E.; Schwartz, J.C.; Ruat, M. The guinea pig histamine H2 receptor: gene cloning, tissue expression and chromosomal localization of its human counterpart. Biochem. Biophys. Res. Commun., 1995, 211, 570.
32. 2+]i in gastric glands. Am. J. Physiol., 1986, 250, G814.198
33. Del Valle, J.; Gantz, I. Novel insights into histamine H2 receptor biology. Am. J. Physiol., 1997, 273, G987.
34. Arrang, J.M.; Garbarg, M.; Schwartz, J.C. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature., 1983, 302, 832.
35. Francis, H.; Franchitto, A.; Ueno, Y.; Glaser, S.; DeMorrow, S.; Venter, J.; Gaudio, E.; Alvaro, D.; Fava, G.; Marzioni, M.; Vaculin, B.; Alpini, G. H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMPdependent PKA/ERK1/2/ELK-1 pathway. Lab Invest., 2007, 87, 473
36. Morisset, S.; Rouleau, A.; Ligneau, X.; Gbahou, F.; Tardivel-Lacombe, J.; Stark, H.; Schunack, W.; Ganellin, C.R.; Schwartz, J.C.; Arrang, J.M. High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature, 2000, 408, 860.
37. Thomas, G.M.; Huganir, R.L. MAPK cascade signalling and synaptic plasticity. Nature Rev. Neuroscience, 2004, 5, 173.
38. Lovenberg, T.W.; Roland, B.L.; Wilson, S.J.; Jiang, X.; Pyati, J.; Huvar, A.; Jackson, M.R.; Erlander, M.G. Cloning and functional expression of the human histamine H3 receptor. Mol. Pharmacol., 1999, 55, 1101.
39. Bongers, G.; Bakker, R.A.; Leurs, R. Molecular aspects of the histamine H3 receptor. Biochem. Pharmacol., 2007, 73, 1195.
40. Cogé, F.; Guénin, S.P.; Audinot, V.; Renouard-Try, A.; Beauverger, P.; Macia, C.; Ouvry, C.; Nagel, C.; Rique, H.; Boutin, A.; Galizzi, J.P. Genomic organization and characterization of splice variants of the human histamine H3 receptor. Biochem. J., 2001, 355, 279.
41. Oda, T.; Marikawa, N.; Saito, Y.; Masuho, Y.; Matsumoto, S.I. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J. Biol. Chem., 2000, 275, 36781.
42. Cogé, F.; Guénin, S.P.; Rique, H.; Boutin, J.A.; Galizzi, J.P. Structure and expression of the human histamine H4-receptor gene. Biochem. Biophys. Res. Commun., 2001, 284, 301.
43. Barnard, R.; Barnard, A.; Salmon, G.; Liu, W.; Sreckovic, S. Histamine-induced actin polymerization in human eosinophils: an imaging approach for histamine H4 receptor. Cytometry, 2008, 73, 299.
44. Damaj, B.B.; Becerre, C.B.; Esber, H.J.; Wen, Y.; Maghazachi, A.A. Functional expression of H4 histamine receptor in human natural killer cells, monocytes and dendritic cells. J. Immunol., 2007, 179, 7907.
45. Horr, B.; Borck, H.; Thurmond, R.; Grösch, S.; Diel, F. STAT1 phosphorylation and cleavage is regulated by the histamine (H4) receptor in human atopic and non-atopic lymphocytes. Int. Immunopharmacol., 2006, 6, 1577.
46. Michel, I.; Borch, H.; mcElligot, S.; Krieg, C.; Diel, F. Histamine receptor H4R-selective ligands influence in STAT6 transcription activation domain (TAD) and the DNA-binding. Inflammation Res., 2008, 57, S47.
47. Zhu, Y.; Michalovich, D.; Wu, H.; Tan, K.B.; Dytko, G.M.; Mannan, I.J.; Boyce, R.; Alston, J.; Tierney, L.A.; Li, X.; Herrity, N.C.; Vawter, L.; Sarau, H.M.; Ames, R.S.; Davenport, C.M.; Hieble, J.P.; Wilson, S.; Bergsma, D.J.; Fitzgerald, L.R. Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol. Pharmacol., 2001, 59, 434.
48. Godot, V.; Arock, M.; Garcia, G.; Capel, F.; Flys, C.; Dy, M.; Emilie, D.; Humbert, M. H4 histamine receptor mediates optimal migration of mast cell precursors to CXCL12. J. Allergy. Clin. Immunol., 2007, 120, 827.
49. Ikawa, Y.; Shiba, K.; Ohki, E.; Mutoh, N.; Suzuki, M.; Sato, H.; Ueno, K. Comparative study of histamine H4 receptor expression in human dermal fibroblasts. J. Toxicol. Sci., 2008, 33, 503.
50. Morini, G.; Becchi, G.; Shenton, F.C.; Chazot, P.L.; Grandi, D. Histamine H3 and H4 receptors are expressed on distinct endocrine cell types in the rat fundic mucosa. Inflamm. Res., 2008, 57, S57.
51. Connelly, W.M.; Shenton, F.C.; Lethbridge, N.; Leurs, R.; Waldvogel, H.J.; Faull, R.L.; Lees, G.; Chazot, P.L. The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS. Br. J. Pharmacol., 2009, 157, 55.
52. Hofstra, C.L.; Desai, P.J.; Thurmond, R.L.; Fung-Leung, W.P. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Ep. Ther., 2003, 305, 1212.
53. van Overveld, F.J. Staub and Bovet Award 1989 lecture. Some aspects of mast cell subtypes from human lung tissue. Agents Actions., 1990, 30, 24.
54. Estelle, F.; Simons, R. Advances in H1-antihistamines. N. Engl. J. Med., 2004, 351, 2203.
55. Simons, F.E. Advances in H1 antihistamines. N. Eng. J. Med., 2004, 351, 2203.
56. Barbey, J.T.; Anderson, M.; Ciprandi, G.; Frew, A.J.; Morad, M.; Priori, S.G.; Ongini, E.; Affrime, M.B. Cardiovascular safety of second-generation antihistamines. Am. J. Rhinol., 1999, 13, 235.
57. Díaz-Trelles, R.; Novelli, A.; Vega, J.A.; Marini, A.; Fernández-Sánchez, M.T. Antihistamine terfenadine potentiates NMDA receptor-mediated calcium influx, oxygen radical formation, and neuronal death. Brain Res., 2000, 880, 17.
58. Okamoto, T.; Iwata, S.; Ohnuma, K.; Dang, N.H.; Morimoto, C. Histamine H1-receptor antagonists with immunomodulating activities: potential use for modulating T helper type 1 (Th1)/Th2 cytokine imbalance and inflammatory responses in allergic diseases. Clin. Exp. Immunol., 2009, 157, 27.
59. Mullol, J.; Roca-Ferrer, J.; Alobad, I.; Pujols, L.; Valero, A.; Xaubet, A.; Bernal-Sprekelsen, M.; Picado, C. Effect of desloratadine on epithelial cell granulocyte-macrophage colonystimulating factor secretion and eosinophil survival. Clin. Exp. Allergy., 2006, 36, 52.
60. Xia, Q.; Yang, S.; Zhang, S.Q.; Chen, B.; Wang, D.B.; Zhu, Q.X.; Wang, Y.; Yan, K.L.; He, P.P.; Zhang, X.J. The effect of mizolastine on expression of vascular endothelial cell growth factor, tumour necrosis factor-alpha and keratinocyte-derived chemokine in murine mast cells, compared with dexamethasone and loratadine. Clin. Exp. Dermatol., 2005, 30, 165.
61. Asano, K.; Kanai, K.; Suzaki, H. Suppressive activity of fexofenadine hydrochloride on thymus-and activation-regulated chemokine production from human peripheral blood leukocytes in response to antigenic stimulation in vitro. Int. Arch. Allergy Immunol., 2004, 133, 267.
62. Leurs, R.; Church, M.K.; Taglialatela, M. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin. Exp. Allergy., 2002, 32, 489.
63. Smit, M.J.; Leurs, R.; Alewijnse, A.E.; Blauw, J.; Van Nieuw Amerongen, G.P.; Van De Vrede, Y.; Roovers, E.; Timmerman, H. Inverse agonism of histamine H2 antagonists accounts for upregulation of spontaneously active histamine H2 receptors. Proc. Natl. Acad. Sci. USA., 1996, 93, 6802.
64. Swanson, D.M.; Shah, C.R.; Lord, B.; Morton, K.; Dvorak, L.K.; Mazu, C.; Apodaca, R.; Xiao, W.; Boggs, J.D.; Feinstein, M.; Wilson, S.J.; Barbier, A.J.; Bonaventure, P.; Lovenberg, T.W.; Carruthers, N.I. Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists. Eur. J. Med. Chem., 2009, 44, 413.
65. Sander, K.; Kottke, T.; Stark, H. Histamine H3 receptor antagonists go to clinics. Biol. Pharm. Bull., 2008, 31, 2163.
66. Leurs, R.; Chazot, P.L.; Shenton, F.C.; Lim, H.D.; de Esch, I.J. Molecular and biochemical pharmacology of the histamine H4 receptor. Br. J. Pharmacol., 2009, 157, 14.
67. Bartholeyns, J.; Fozar, J.R. Role of histamine in tumor development. Trends Pharmacol. Sci., 1985, 6, 123.
68. Rivera, E.S.; Cricco, G.P.; Engel, N.I.; Fitzsimons, C.P.; Martín, G.A.; Bergoc, R.M. Histamine as an autocrine growth factor: an unusual role for a widespread mediator. Semin. Cancer Biol., 2000, 10, 15.
69. Bartholeyns, J.; Bouclier, M. Involvement of histamine in growth of mouse and rat tumors: antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase. Cancer Res., 1984, 44, 639.
70. Malaviya, R.; Uckun, F.M. Histamine as an autocrine regulator of leukemic cell proliferation. Leuk. Lymphoma., 2000, 36, 367.
71. Lazar-Molnar, E.; Cricco, G.; Martin, C.G.; Darvas, Z.; Hegyesi, H.; Fitzsimons, C.; Bergoc, R.; Falus, A.; Rivera, E. Histamine as a potential autocrine regulator of melanoma. Inflamm. Res., 2001, 50, S102.
72. Tomita, K.; Okabe, S. Exogenous histamine stimulates colorectal cancer implant growth via immunosuppression in mice. J. Pharm. Sci., 2005, 97, 116.
73. +2-mobilizing H1 receptors. J. Cell Biol., 1990, 110, 1211.
74. +2-mobilizing H1 receptors. J. Cell Biol., 1990, 110, 1211.
75. Martín, G.; Cricco, G.; Darvas, Z.; Croci, M.; Núñez, M.; Bergoc, R.; Falus, A.; Rivera, E. Histamine inhibits proliferation of a pancreatic carcinoma cell line without inducing apoptosis significantly. Inflamm. Res., 2002, 51, S67.
76. Molnár, E.L.; Hegyesi, H.; Tóth, S.; Darvas, Z.; László, V.; Szalai, C.; Falus, A. Biosynthesis of interleukin-6, an autocrine growth factor for melanoma, is regulated by melanoma-derived histamine. Semin. Cancer Biol., 2000, 10, 25.
77. Medina, V.; Cricco, G.; Nuñez, M.; Martin, G.; Mohamad, N.; Correa-Fiz, F.; Sanchez-Jimenez, F.; Bergoc, R,; Rivera, E.S. Histamine-mediated signaling processes in human malignant mammary cells. Cancer Biol. Ther., 2006, 5, 1462.
78. Szabó, P.M.; Wiener, Z.; Tömböl, Z.; Kovács, A.; Pócza, P.; Horányi, J.; Kulka, J.; Riesz, P.; Tóth, M.; Patócs, A.; Gaillard, R.C.; Falus, A.; Rácz, K.; Igaz, P. Differences in the expression of histamine-related genes and proteins in normal human adrenal cortex and adrenocortical tumors. Virchow Arch., 2009, 455, 133.
79. Nissinen, M.J.; Karlstedt, K.; Castren, E.; Panula, P. Expression of histidine decarboxylase and cellular histamine-like immunoreactivity in rat embryogenesis. J. Histochem. Cytochem., 1995, 43, 1241.
80. Fitzpatrick, D.W.; Fisher, H. Histamine synthesis, imidazole dipeptides, and wound healing. Surgery, 1982, 91, 430.
81. Cianchi, F.; Cortesini, C.; Schiavone, N.; Perna, F.; Magnelli, L.; Fanti, E.; Bani, D.; Messerini, L.; Fabbroni, V.; Perigli, G.; Capaccioli, S.; Masini, E. Histamine and histidine decarboxylase up-regulation in colorectal cancer: correlation with tumor stage. Clin. Cancer Res., 2005, 11, 6807.
82. Masini, E.; Fabbroni, V.; Giannini, L.; Vannaci, A.; Messerini, L.; Perna, F.; Cortesini, C.; Cianchi, F. Histamine and histidine decarboxylase up-regulation in colorectal cancer: correlation with tumor stage. Inflamm. Res., 2005, 54, S80.
83. Pos, Z.; Safrany, G.; Muller, K.; Coth, S.; Falus, A.; Hegyesi, H. Phenotypic profiling of engineered mouse melanomas with manipulated histamine production identifies histamine H2 receptor and Rho-C as histamine-regulated melanoma progression markers. Cancer Res., 2005, 65, 4458.
84. Genre, F.; Valli, E.; Medina, V.; Gutierrez, A.; Sambuco, L.; Rivera, E.; Cricco, G.; Martin, G. Effect of histamine on the expression of metalloproteinases and cell adhesion in breast cancer cell lines. Inflamm. Res., 2009, Sup I, S55.
85. Cricco, G.; Martín, G.; Medina, V.; Núñez, M.; Mohamad, N.; Croci, M.; Crescenti, E.; Bergoc, R.; Rivera, E. Histamine inhibits cell proliferation and modulates the expression of Bcl-2 family proteins via the H2 receptor in human pancreatic cancer cells. Anticancer Res., 2006, 26, 4443.
86. Cricco, G.; Núñez, M.; Medina, V.; Garbarino, G.; Mohamad, N.; Gutiérrez, A.; Cocca, C.; Bergoc, R.; Rivera, E.; Martín, G. Histamine modulates cellular events involved in tumour invasiveness in pancreatic carcinoma cells. Inflamm. Res., 2006, 55, Suppl, 1:S83.
87. Hellstrand, K.; Brune, M.; Naredi, P.; Mellqvist, U.H.; Hansson, M.; Gehlsen, K.R.; Hermodsson, S. Histamine: a novel approach to cancer immunotherapy. Cancer Invest., 2000, 18, 347.
88. Perz, J.B.; Ho, A.D. Histamine dihydrochroride for the treatment of acute myeloig leukaemia, malignant melanoma and renal cell carcinoma. Future Oncol., 2008, 4, 169.
89. Dahlgren, C.; Hansson, M.; Hermodsson, S.; Lindner, P. Alleviating oxidative stress in cancer immunotherapy: a role for histamine?. Med. Oncol., 2000, 17, 258.
90. Middleton, M.; Sarno, M.; Agarwala, S.S.; Glaspy, J.; Laurent, A.; McMasters, K.; Naredi, P.; O'Day, S.; Whitman, E.; Danson, S.; Cosford, R.; Gehlsen, K. Pharmacokinetics of histamine didydrochloride in healthy volunteers and cancer patients: implications for combined immunotherapy with interleukin-2. J. Clin. Pharmacol., 2002, 42, 774.
91. Tomita, K.; Okabe, S. Exogenous histamine stimulates colorectal cancer implant growth via immunosuppression in mice. J. Pharmacol. Sci., 2005, 97, 116.
92. Medina, V.A.; Massari, N.A.; Cricco, G.P.; Martin, G.A.; Bergoc, R.M.; Rivera, E.S. Involvement of hydrogen peroxide in histamineinduced modulation of WM35 human malignat melanoma cell proliferation. Free Radic. Biol. Med., 2009, 46, 1510.
93. Lampiasi, N.; Azzolina, A.; Montalto, G.; Cervello, M. Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells. Exp. Mol. Med., 2007, 39, 284.
94. Kapoor, S.; Pal, S.; Sahni, P.; Dattagupta, S.; Chattopadhyay, T. Effect of pre-operative short course famotidine on tumor infiltrating lymphocytes in colorectal cancer: a double blind, placebo controlled, prospective randomized study. J. Surg. Res. 2005, 129, 172.
95. Jangi, S.M.; Asumendi, A.; Arlucea, J.; Nieto, N.; Perez-Yarza, G.; Morales, M.C.; de la Fuente-Pinedo, M.; Boyano, M.D. Apoptosis of human T-cell acute lymphoblastic leukaemia cells by Diphenhydramine, an H1 histamine receptor antagonist. Oncol. Res., 2004, 14, 363.
96. Jangi, S.M.; Díaz-Pérez, J.L.; Ochoa-Lizarralde, B.; Martín-Ruiz, I.; Asumendi, A.; Perez-Yarza, Gardeazabal, J.; Díaz-Ramón, J.L.; Boyano, M.D. Hi histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells. Carcinogenesis, 2006, 27, 1787.
97. Jangi, S.M.; Ruiz-Larrea, M.B.; Nicolau-Galmés, F.; Andollo, N.; Arroyo-Berdugo, Y.; Ortega-Martínez, I.; Díaz-Pérez, J.L.; Boyano, M.D. Terfenadine-induced apoptosis in human melanoma cells is mediated through Ca2+ homeostasis modulation and tyrosine kinase activity, independently of H1 histamine receptors. Carcinogenesis, 2008, 29, 500.
98. Okamoto, T.; Iwata, S.; Ohnuma, K.; Dang, N.H.; Morimoto, C. Histamine H1-receptor antagonists with immunomodulating activities: potential use for modulating T helper type 1 (Th1)/Th2 cytokine imbalance and inflammatory responses in allergic disease. Clin. Exp. Immunol., 2009, 157, 27.
99. Paoluzzi, L.; Scotto, L.; Marchi, E.; Seshan, V.E.; O'Connor, O.A. The Anti-histamine cyproheptadine synergizes the antineoplastic activity of bortezomib in mantle cell lymphoma through its effects as a histone deacetylase inhibitor. Br. J. Haematol., 2009, 146, 656.
100. Soule, B.P.; Simone, N.L.; DeGraff, W.G.; Choudhuri, R.; Cook, J.A.; Mitchell, J.B. Loratadine dysregulates cell cycle progression and enhaces the effect of radiation in human tumor cell lines. Radiat. Oncol., 2010, 3, 5.
101. Jiang, C.G.; Liu, F.R.; Yu, M.; Li, J.B.; Xu, H.M. Cimetidine induces apoptosis in gastric cancer cells in vitro and inhibits tumor growth in vivo. Oncol. Rep., 2010, 23,371-693.